| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C3b binding | 6.33e-08 | 12 | 69 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | complement binding | 7.96e-08 | 32 | 69 | 5 | GO:0001848 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.56e-06 | 25 | 69 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement component C3b receptor activity | 1.18e-05 | 2 | 69 | 2 | GO:0004877 | |
| GeneOntologyMolecularFunction | complement component C4b receptor activity | 1.18e-05 | 2 | 69 | 2 | GO:0001861 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.40e-05 | 14 | 69 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | complement component C4b binding | 3.52e-05 | 3 | 69 | 2 | GO:0001855 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.39e-04 | 749 | 69 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | immune receptor activity | 2.66e-04 | 165 | 69 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 3.25e-04 | 8 | 69 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 8.96e-04 | 13 | 69 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | metalloendopeptidase inhibitor activity | 1.37e-03 | 16 | 69 | 2 | GO:0008191 | |
| GeneOntologyMolecularFunction | cytokine binding | 2.14e-03 | 157 | 69 | 4 | GO:0019955 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 7.95e-09 | 8 | 69 | 4 | GO:0045959 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 2.37e-08 | 10 | 69 | 4 | GO:0030450 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 5.56e-08 | 12 | 69 | 4 | GO:0002924 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 1.12e-07 | 14 | 69 | 4 | GO:0045916 | |
| GeneOntologyBiologicalProcess | complement activation | 1.24e-07 | 70 | 69 | 6 | GO:0006956 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 2.02e-07 | 16 | 69 | 4 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 2.02e-07 | 16 | 69 | 4 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 4.28e-07 | 19 | 69 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 8.02e-07 | 22 | 69 | 4 | GO:0002923 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.90e-06 | 27 | 69 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 8.58e-06 | 83 | 69 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.27e-05 | 14 | 69 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.41e-05 | 44 | 69 | 4 | GO:0006958 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.75e-05 | 96 | 69 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.96e-05 | 166 | 69 | 6 | GO:0002698 | |
| GeneOntologyBiologicalProcess | immune effector process | SLAMF8 CFHR1 CFHR2 TRAF2 CLEC2D MUC19 CR1 CR1L CR2 ACE SVEP1 MYB | 2.49e-05 | 859 | 69 | 12 | GO:0002252 |
| GeneOntologyBiologicalProcess | hemopoiesis | SLAMF8 FAM20C FBN1 CLEC2D MUC19 TMEM131L CR1 CR2 FST ACE APOBEC3B MYB APOBEC3F GP9 | 4.42e-05 | 1223 | 69 | 14 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 4.86e-05 | 60 | 69 | 4 | GO:0002920 | |
| GeneOntologyBiologicalProcess | defense response to other organism | TRIM43B SLAMF8 SELP CFHR1 CFHR2 TRAF2 CLEC2D MUC19 TRIM43 CST11 CR1 CR1L CR2 APOBEC3B APOBEC3F | 5.11e-05 | 1407 | 69 | 15 | GO:0098542 |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 5.11e-05 | 197 | 69 | 6 | GO:0002244 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 5.53e-05 | 62 | 69 | 4 | GO:0002455 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.07e-05 | 66 | 69 | 4 | GO:0002823 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 8.82e-05 | 26 | 69 | 3 | GO:0042454 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 9.41e-05 | 71 | 69 | 4 | GO:0002820 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.26e-04 | 232 | 69 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 1.43e-04 | 79 | 69 | 4 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 1.43e-04 | 79 | 69 | 4 | GO:0002889 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.48e-04 | 239 | 69 | 6 | GO:0050777 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.64e-04 | 6 | 69 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.64e-04 | 6 | 69 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 1.66e-04 | 32 | 69 | 3 | GO:0009164 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 2.57e-04 | 37 | 69 | 3 | GO:0034656 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | TRIM43B SLAMF8 CFHR1 CFHR2 TRAF2 CLEC2D MUC19 TRIM43 CR1 CR1L CR2 APOBEC3B APOBEC3F | 2.96e-04 | 1286 | 69 | 13 | GO:0140546 |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 3.49e-04 | 41 | 69 | 3 | GO:1901658 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 4.88e-04 | 10 | 69 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytolysis by host of symbiont cells | 4.88e-04 | 10 | 69 | 2 | GO:0051838 | |
| GeneOntologyBiologicalProcess | myeloid cell development | 4.90e-04 | 109 | 69 | 4 | GO:0061515 | |
| GeneOntologyBiologicalProcess | mature B cell differentiation | 5.23e-04 | 47 | 69 | 3 | GO:0002335 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 5.56e-04 | 48 | 69 | 3 | GO:0009119 | |
| GeneOntologyBiologicalProcess | cell killing | 5.65e-04 | 307 | 69 | 6 | GO:0001906 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 5.67e-04 | 201 | 69 | 5 | GO:0030183 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 5.85e-04 | 309 | 69 | 6 | GO:0002703 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 7.12e-04 | 12 | 69 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | humoral immune response | 7.13e-04 | 321 | 69 | 6 | GO:0006959 | |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 8.40e-04 | 13 | 69 | 2 | GO:1903659 | |
| GeneOntologyBiologicalProcess | innate immune response | TRIM43B SLAMF8 TRAF2 CLEC2D MUC19 TRIM43 CR1 CR1L CR2 APOBEC3B APOBEC3F | 9.42e-04 | 1092 | 69 | 11 | GO:0045087 |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 9.78e-04 | 14 | 69 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | DNA deamination | 9.78e-04 | 14 | 69 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 9.78e-04 | 14 | 69 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 9.78e-04 | 14 | 69 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.14e-03 | 235 | 69 | 5 | GO:0002822 | |
| GeneOntologyBiologicalProcess | negative regulation of immune system process | 1.19e-03 | 631 | 69 | 8 | GO:0002683 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 1.22e-03 | 789 | 69 | 9 | GO:0002521 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.28e-03 | 16 | 69 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | complement receptor mediated signaling pathway | 1.28e-03 | 16 | 69 | 2 | GO:0002430 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 1.28e-03 | 16 | 69 | 2 | GO:0097278 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 1.28e-03 | 16 | 69 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 1.28e-03 | 16 | 69 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 1.34e-03 | 497 | 69 | 7 | GO:0002697 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.41e-03 | 66 | 69 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | blood coagulation, fibrin clot formation | 1.45e-03 | 17 | 69 | 2 | GO:0072378 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.48e-03 | 249 | 69 | 5 | GO:0007565 | |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 1.54e-03 | 68 | 69 | 3 | GO:0009116 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.56e-03 | 252 | 69 | 5 | GO:0002819 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 1.63e-03 | 18 | 69 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 1.65e-03 | 151 | 69 | 4 | GO:1902106 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 1.82e-03 | 19 | 69 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 1.82e-03 | 19 | 69 | 2 | GO:0016553 | |
| GeneOntologyBiologicalProcess | gap junction assembly | 1.82e-03 | 19 | 69 | 2 | GO:0016264 | |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.82e-03 | 19 | 69 | 2 | GO:0006957 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-2 production | 1.96e-03 | 74 | 69 | 3 | GO:0032663 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.99e-03 | 159 | 69 | 4 | GO:1903707 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 2.02e-03 | 20 | 69 | 2 | GO:0039692 | |
| MousePheno | tight skin | 2.78e-05 | 14 | 61 | 3 | MP:0001198 | |
| Domain | Sushi | 2.42e-13 | 52 | 69 | 9 | PF00084 | |
| Domain | CCP | 3.48e-13 | 54 | 69 | 9 | SM00032 | |
| Domain | SUSHI | 4.93e-13 | 56 | 69 | 9 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.83e-13 | 57 | 69 | 9 | IPR000436 | |
| Domain | EGF_3 | 2.54e-05 | 235 | 69 | 7 | PS50026 | |
| Domain | EGF | 2.54e-05 | 235 | 69 | 7 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 2.94e-05 | 97 | 69 | 5 | IPR018097 | |
| Domain | EGF_CA | 3.25e-05 | 99 | 69 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.41e-05 | 100 | 69 | 5 | PS00010 | |
| Domain | EGF-like_dom | 3.67e-05 | 249 | 69 | 7 | IPR000742 | |
| Domain | EGF_1 | 4.27e-05 | 255 | 69 | 7 | PS00022 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.51e-05 | 106 | 69 | 5 | IPR000152 | |
| Domain | EGF_2 | 5.45e-05 | 265 | 69 | 7 | PS01186 | |
| Domain | EGF_CA | 8.81e-05 | 122 | 69 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 9.52e-05 | 124 | 69 | 5 | IPR001881 | |
| Domain | C_TYPE_LECTIN_1 | 2.18e-04 | 80 | 69 | 4 | PS00615 | |
| Domain | Lectin_C | 2.63e-04 | 84 | 69 | 4 | PF00059 | |
| Domain | CLECT | 2.63e-04 | 84 | 69 | 4 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 2.76e-04 | 85 | 69 | 4 | PS50041 | |
| Domain | Growth_fac_rcpt_ | 2.79e-04 | 156 | 69 | 5 | IPR009030 | |
| Domain | C-type_lectin-like | 2.88e-04 | 86 | 69 | 4 | IPR001304 | |
| Domain | EGF_CA | 2.88e-04 | 86 | 69 | 4 | PF07645 | |
| Domain | Kazal_2 | 3.16e-04 | 36 | 69 | 3 | PF07648 | |
| Domain | EGF-like_CS | 4.04e-04 | 261 | 69 | 6 | IPR013032 | |
| Domain | - | 4.56e-04 | 97 | 69 | 4 | 3.10.100.10 | |
| Domain | TB | 4.76e-04 | 9 | 69 | 2 | PS51364 | |
| Domain | TB_dom | 4.76e-04 | 9 | 69 | 2 | IPR017878 | |
| Domain | C-type_lectin-like/link | 4.93e-04 | 99 | 69 | 4 | IPR016186 | |
| Domain | KAZAL | 6.54e-04 | 46 | 69 | 3 | SM00280 | |
| Domain | CTDL_fold | 6.61e-04 | 107 | 69 | 4 | IPR016187 | |
| Domain | Pentaxin-related | 7.24e-04 | 11 | 69 | 2 | IPR001759 | |
| Domain | - | 7.24e-04 | 11 | 69 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 7.24e-04 | 11 | 69 | 2 | IPR023413 | |
| Domain | Pentaxin | 7.24e-04 | 11 | 69 | 2 | PF00354 | |
| Domain | KAZAL_2 | 8.35e-04 | 50 | 69 | 3 | PS51465 | |
| Domain | APOBEC_N | 8.67e-04 | 12 | 69 | 2 | PF08210 | |
| Domain | TIL | 8.67e-04 | 12 | 69 | 2 | PF01826 | |
| Domain | APOBEC_N | 8.67e-04 | 12 | 69 | 2 | IPR013158 | |
| Domain | C8 | 8.67e-04 | 12 | 69 | 2 | PF08742 | |
| Domain | Kazal_dom | 8.85e-04 | 51 | 69 | 3 | IPR002350 | |
| Domain | Unchr_dom_Cys-rich | 1.02e-03 | 13 | 69 | 2 | IPR014853 | |
| Domain | C8 | 1.02e-03 | 13 | 69 | 2 | SM00832 | |
| Domain | TIL_dom | 1.19e-03 | 14 | 69 | 2 | IPR002919 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.19e-03 | 14 | 69 | 2 | IPR016192 | |
| Domain | EGF | 1.22e-03 | 126 | 69 | 4 | PF00008 | |
| Domain | ConA-like_dom | 1.29e-03 | 219 | 69 | 5 | IPR013320 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.37e-03 | 15 | 69 | 2 | PS51747 | |
| Domain | VWD | 1.56e-03 | 16 | 69 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.56e-03 | 16 | 69 | 2 | IPR001846 | |
| Domain | VWFD | 1.56e-03 | 16 | 69 | 2 | PS51233 | |
| Domain | VWD | 1.56e-03 | 16 | 69 | 2 | PF00094 | |
| Domain | TSP_1 | 1.64e-03 | 63 | 69 | 3 | PF00090 | |
| Domain | Cytidine_deaminase-like | 1.76e-03 | 17 | 69 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 1.76e-03 | 17 | 69 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 1.76e-03 | 17 | 69 | 2 | IPR002125 | |
| Domain | TSP1 | 1.79e-03 | 65 | 69 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.79e-03 | 65 | 69 | 3 | IPR000884 | |
| Domain | TSP1 | 1.79e-03 | 65 | 69 | 3 | PS50092 | |
| Domain | CTCK_1 | 1.98e-03 | 18 | 69 | 2 | PS01185 | |
| Domain | KAZAL_1 | 1.98e-03 | 18 | 69 | 2 | PS00282 | |
| Domain | VWC_out | 2.21e-03 | 19 | 69 | 2 | SM00215 | |
| Domain | CT | 2.96e-03 | 22 | 69 | 2 | SM00041 | |
| Domain | NTR | 3.24e-03 | 23 | 69 | 2 | PS50189 | |
| Domain | Netrin_domain | 3.24e-03 | 23 | 69 | 2 | IPR001134 | |
| Domain | Cys_knot_C | 3.82e-03 | 25 | 69 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.82e-03 | 25 | 69 | 2 | PS01225 | |
| Domain | TIMP-like_OB-fold | 4.13e-03 | 26 | 69 | 2 | IPR008993 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.46e-05 | 109 | 51 | 5 | MM15164 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.04e-04 | 68 | 51 | 4 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.38e-04 | 73 | 51 | 4 | MM15906 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 1.91e-04 | 6 | 51 | 2 | M47880 | |
| Pathway | WP_16P112_DISTAL_DELETION_SYNDROME | 2.25e-04 | 33 | 51 | 3 | M40056 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 2.66e-04 | 7 | 51 | 2 | MM15412 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.72e-04 | 39 | 51 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.72e-04 | 39 | 51 | 3 | MM15165 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 3.95e-04 | 96 | 51 | 4 | M39581 | |
| Pathway | REACTOME_MRNA_EDITING | 4.55e-04 | 9 | 51 | 2 | MM15445 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.84e-04 | 111 | 51 | 4 | M27416 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 7.82e-04 | 115 | 51 | 4 | M19752 | |
| Pubmed | Complement-dependent P-selectin expression and injury following ischemic stroke. | 7.08e-11 | 5 | 69 | 4 | 17082645 | |
| Pubmed | 4.63e-09 | 11 | 69 | 4 | 1543915 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2528587 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 7528766 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 2139460 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | SLAMF8 CFHR1 CFHR2 FNDC3B IL12RB2 TRAF2 UBE2O SLITRK3 CR1 CR2 ACE F13B CNTFR | 7.68e-09 | 824 | 69 | 13 | 20237496 |
| Pubmed | 1.00e-08 | 13 | 69 | 4 | 16002709 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 16127466 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 30217731 | ||
| Pubmed | 7.45e-08 | 5 | 69 | 3 | 20962256 | ||
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 4.16e-07 | 8 | 69 | 3 | 2564419 | |
| Pubmed | Mouse kalinin B1 (laminin beta 3 chain): cloning and tissue distribution. | 4.16e-07 | 8 | 69 | 3 | 7898049 | |
| Pubmed | Functional identification of transcription control sequences of the mouse Crry gene. | 3.88e-06 | 2 | 69 | 2 | 8335915 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 32636836 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14635039 | ||
| Pubmed | Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. | 3.88e-06 | 2 | 69 | 2 | 10779754 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16444293 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1730912 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12242034 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 19740350 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26057128 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11981823 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31726086 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2952719 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1708808 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12767833 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20484840 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17674370 | ||
| Pubmed | Molecular cloning of a human serum protein structurally related to complement factor H. | 3.88e-06 | 2 | 69 | 2 | 1711047 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11698469 | ||
| Pubmed | Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones. | 3.88e-06 | 2 | 69 | 2 | 34709768 | |
| Pubmed | The murine complement regulator Crry: new insights into the immunobiology of complement regulation. | 3.88e-06 | 2 | 69 | 2 | 11915940 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 7691944 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 33651882 | ||
| Pubmed | Comparative functional evolution of human and mouse CR1 and CR2. | 3.88e-06 | 2 | 69 | 2 | 18713965 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2911011 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12902517 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17015675 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23153828 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 37833411 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26189291 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12973023 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 23440418 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 10586048 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16301687 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 36450590 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 16301324 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 2307848 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21380996 | ||
| Pubmed | Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. | 4.11e-06 | 16 | 69 | 3 | 33904407 | |
| Pubmed | 5.97e-06 | 18 | 69 | 3 | 17702963 | ||
| Pubmed | 9.69e-06 | 21 | 69 | 3 | 8138038 | ||
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.16e-05 | 3 | 69 | 2 | 27602762 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.16e-05 | 3 | 69 | 2 | 22666481 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 2295627 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.16e-05 | 3 | 69 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.16e-05 | 3 | 69 | 2 | 23533681 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.16e-05 | 3 | 69 | 2 | 25589647 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 9765497 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 31273197 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23449789 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 11907125 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 286744 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20660348 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24725948 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 284359 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 31801862 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 31943071 | ||
| Pubmed | [Hepatitis B virus X protein upregulates the expression of CD59 and Crry in mouse podocytes]. | 1.16e-05 | 3 | 69 | 2 | 21215189 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.16e-05 | 3 | 69 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.16e-05 | 3 | 69 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.16e-05 | 3 | 69 | 2 | 25505062 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 31595054 | ||
| Pubmed | A critical role for murine complement regulator crry in fetomaternal tolerance. | 1.16e-05 | 3 | 69 | 2 | 10642554 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.16e-05 | 3 | 69 | 2 | 17967065 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.16e-05 | 3 | 69 | 2 | 29593034 | |
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.16e-05 | 3 | 69 | 2 | 21998583 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 2157836 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.16e-05 | 3 | 69 | 2 | 12466850 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.16e-05 | 3 | 69 | 2 | 32641479 | |
| Pubmed | Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. | 1.16e-05 | 3 | 69 | 2 | 7690834 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.16e-05 | 3 | 69 | 2 | 24577894 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 1541833 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 27356895 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 3782802 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.16e-05 | 3 | 69 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.16e-05 | 3 | 69 | 2 | 24840555 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24453360 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24850152 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.16e-05 | 3 | 69 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.16e-05 | 3 | 69 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.16e-05 | 3 | 69 | 2 | 18772436 | |
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.16e-05 | 3 | 69 | 2 | 18786991 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 34938350 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20702647 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20980520 | ||
| Interaction | CR1 interactions | 2.03e-06 | 8 | 68 | 3 | int:CR1 | |
| Cytoband | 1q32 | 5.70e-05 | 49 | 69 | 3 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 2.03e-04 | 75 | 69 | 3 | chr1q31 | |
| Cytoband | 2q11.1 | 8.21e-04 | 28 | 69 | 2 | 2q11.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 9.76e-04 | 290 | 69 | 4 | chr1q32 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.42e-14 | 57 | 48 | 9 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 3.77e-08 | 36 | 48 | 5 | 492 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.54e-05 | 394 | 48 | 7 | 471 | |
| GeneFamily | C-type lectin domain family | 2.62e-04 | 47 | 48 | 3 | 494 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 4.48e-04 | 12 | 48 | 2 | 406 | |
| GeneFamily | CD molecules|Mucins | 1.40e-03 | 21 | 48 | 2 | 648 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.73e-03 | 53 | 48 | 2 | 532 | |
| GeneFamily | Fibronectin type III domain containing | 8.79e-03 | 160 | 48 | 3 | 555 | |
| Coexpression | NABA_MATRISOME | FAM20C INHBE FBN1 OIT3 IGFBP1 EGF SEMA5B TIMP4 WFIKKN2 CLEC2D ADAMTS17 MUC19 CST11 FST MUC5AC SVEP1 F13B | 6.98e-10 | 1008 | 69 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | FAM20C INHBE FBN1 OIT3 IGFBP1 EGF SEMA5B TIMP4 WFIKKN2 CLEC2D ADAMTS17 MUC19 CST11 FST MUC5AC SVEP1 F13B | 9.13e-10 | 1026 | 69 | 17 | M5889 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | FAM20C INHBE EGF SEMA5B TIMP4 WFIKKN2 CLEC2D ADAMTS17 MUC19 CST11 FST MUC5AC F13B | 5.70e-08 | 738 | 69 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | FAM20C INHBE EGF SEMA5B TIMP4 WFIKKN2 CLEC2D ADAMTS17 MUC19 CST11 FST MUC5AC F13B | 6.97e-08 | 751 | 69 | 13 | M5885 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 9.24e-06 | 445 | 66 | 9 | GSM777043_500 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.05e-07 | 163 | 69 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-07 | 190 | 69 | 6 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.19e-07 | 191 | 69 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 192 | 69 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 192 | 69 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 192 | 69 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-07 | 193 | 69 | 6 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-07 | 194 | 69 | 6 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 6.04e-07 | 196 | 69 | 6 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.60e-07 | 199 | 69 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 139 | 69 | 5 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 139 | 69 | 5 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 139 | 69 | 5 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 139 | 69 | 5 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.34e-06 | 168 | 69 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.51e-06 | 174 | 69 | 5 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 7.51e-06 | 174 | 69 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-06 | 174 | 69 | 5 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.72e-06 | 175 | 69 | 5 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 176 | 69 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-06 | 180 | 69 | 5 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.85e-06 | 180 | 69 | 5 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 9.10e-06 | 181 | 69 | 5 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-06 | 181 | 69 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-06 | 182 | 69 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-06 | 182 | 69 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 183 | 69 | 5 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 185 | 69 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 185 | 69 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 185 | 69 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 185 | 69 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.04e-05 | 186 | 69 | 5 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 186 | 69 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.04e-05 | 186 | 69 | 5 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.04e-05 | 186 | 69 | 5 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 187 | 69 | 5 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 189 | 69 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 189 | 69 | 5 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.18e-05 | 191 | 69 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 191 | 69 | 5 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.18e-05 | 191 | 69 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 191 | 69 | 5 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.21e-05 | 192 | 69 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 192 | 69 | 5 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.24e-05 | 193 | 69 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.27e-05 | 194 | 69 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 69 | 5 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 69 | 5 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.27e-05 | 194 | 69 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 194 | 69 | 5 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 194 | 69 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.27e-05 | 194 | 69 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 69 | 5 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.30e-05 | 195 | 69 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 196 | 69 | 5 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 196 | 69 | 5 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 196 | 69 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.34e-05 | 196 | 69 | 5 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 197 | 69 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 197 | 69 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 197 | 69 | 5 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 197 | 69 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 69 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 199 | 69 | 5 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.47e-05 | 200 | 69 | 5 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 200 | 69 | 5 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.47e-05 | 200 | 69 | 5 | 687cfada2d0977e8985e0a73a5804f84f2ca9c52 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 200 | 69 | 5 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Rbp4_(Rbp4)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-05 | 105 | 69 | 4 | cec0bdfe2bbd87c7e84671c1eeafad17aec1cdb2 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2-Endothelial_Tip.Dcn.Rbp4_(Rbp4)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-05 | 105 | 69 | 4 | c4b3f085c7e372e529d2c5d275faba403e830d48 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.15e-05 | 105 | 69 | 4 | dc5f6d62945a699734a71b8ab1d4266db6fb2918 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Solid_Pattern_Predominant_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.98e-05 | 114 | 69 | 4 | 9c304f7a8584baccb591a873c67c5b57945cce44 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Solid_Pattern_Predominant_Adenocarcinoma-1|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.08e-05 | 115 | 69 | 4 | 891a2c68472c2a633fc1864a9c3debc3b5ae1b77 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-05 | 119 | 69 | 4 | 018162114bc22a9780fded5887f1f78211851700 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-05 | 139 | 69 | 4 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.45e-05 | 139 | 69 | 4 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.45e-05 | 139 | 69 | 4 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.60e-05 | 145 | 69 | 4 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | Healthy_donor-RBC|World / disease group, cell group and cell class (v2) | 8.67e-05 | 150 | 69 | 4 | 1e1a497ec4b048f7e9cc12dd5dd9aba7fedca9e1 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 151 | 69 | 4 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 151 | 69 | 4 | 523dcd243c285a6b74830a93c82cca8784edd658 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 151 | 69 | 4 | f3406094ce79cc80398b82d58ca6fd87a96e68d4 | |
| ToppCell | Healthy_donor-RBC|Healthy_donor / disease group, cell group and cell class (v2) | 9.60e-05 | 154 | 69 | 4 | e080d5104fe6f3f6ef617bbcdccf1332ab7231e1 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 9.84e-05 | 155 | 69 | 4 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 156 | 69 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 156 | 69 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 158 | 69 | 4 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 1.09e-04 | 159 | 69 | 4 | 595643e9433265308e5aab7f906229025701cf6a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 160 | 69 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Healthy/Control-RBC|World / Disease group and Cell class | 1.11e-04 | 160 | 69 | 4 | f10871238e7bdf3e1f65a17070000477196e50fe | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Platelet|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 160 | 69 | 4 | e0591f95f3f47ffbe013ebbebf6bed8c7c344732 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 160 | 69 | 4 | 08696d93ff42a1beca23c70ab3e0d082cfff4aa7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 160 | 69 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.29e-05 | 24 | 68 | 3 | DOID:1184 (implicated_via_orthology) | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.29e-05 | 24 | 68 | 3 | DOID:12894 (is_marker_for) | |
| Disease | Weill-Marchesani syndrome | 3.13e-05 | 4 | 68 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 3.13e-05 | 4 | 68 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | complement factor H-related protein 2 measurement | 4.10e-05 | 29 | 68 | 3 | EFO_0600055 | |
| Disease | contactin-1 measurement | 7.80e-05 | 6 | 68 | 2 | EFO_0020286 | |
| Disease | blood sedimentation | 1.09e-04 | 7 | 68 | 2 | EFO_0004304 | |
| Disease | complement factor H-related protein 5 measurement | 1.26e-04 | 42 | 68 | 3 | EFO_0008098 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.86e-04 | 9 | 68 | 2 | DOID:988 (is_implicated_in) | |
| Disease | C3 glomerulopathy | 1.86e-04 | 9 | 68 | 2 | C4087273 | |
| Disease | cholestasis (biomarker_via_orthology) | 2.00e-04 | 49 | 68 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | complement factor H-related protein 1 measurement | 2.97e-04 | 56 | 68 | 3 | EFO_0600054 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.83e-04 | 61 | 68 | 3 | DOID:3587 (is_marker_for) | |
| Disease | intermediate coronary syndrome (is_marker_for) | 4.02e-04 | 13 | 68 | 2 | DOID:8805 (is_marker_for) | |
| Disease | Depressed mood | 4.02e-04 | 13 | 68 | 2 | C0344315 | |
| Disease | interstitial lung disease | 5.05e-04 | 67 | 68 | 3 | EFO_0004244 | |
| Disease | respiratory symptom measurement, COVID-19 | 6.75e-04 | 74 | 68 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | renal fibrosis (implicated_via_orthology) | 6.96e-04 | 17 | 68 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 8.72e-04 | 19 | 68 | 2 | EFO_0002609, GO_0031427 | |
| Disease | HbA1c measurement | 9.20e-04 | 675 | 68 | 7 | EFO_0004541 | |
| Disease | corneal hysteresis | 9.68e-04 | 20 | 68 | 2 | EFO_0010066 | |
| Disease | QRS duration, response to sulfonylurea | 1.28e-03 | 23 | 68 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Cancer of Head | 1.40e-03 | 24 | 68 | 2 | C0751177 | |
| Disease | Head Neoplasms | 1.40e-03 | 24 | 68 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.40e-03 | 24 | 68 | 2 | C0887900 | |
| Disease | Calcium channel blocker use measurement | 1.50e-03 | 213 | 68 | 4 | EFO_0009930 | |
| Disease | Neck Neoplasms | 1.52e-03 | 25 | 68 | 2 | C0027533 | |
| Disease | Cancer of Neck | 1.52e-03 | 25 | 68 | 2 | C0746787 | |
| Disease | platelet component distribution width | 1.75e-03 | 755 | 68 | 7 | EFO_0007984 | |
| Disease | acute kidney failure (implicated_via_orthology) | 1.77e-03 | 27 | 68 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 1.90e-03 | 28 | 68 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.96e-03 | 107 | 68 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 2.01e-03 | 774 | 68 | 7 | C0023893 | |
| Disease | hair morphology | 2.04e-03 | 29 | 68 | 2 | EFO_0005038 | |
| Disease | Thrombocytopenia | 2.04e-03 | 29 | 68 | 2 | C0040034 | |
| Disease | Age related macular degeneration | 2.18e-03 | 30 | 68 | 2 | C0242383 | |
| Disease | forced expiratory volume | 2.24e-03 | 789 | 68 | 7 | EFO_0004314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWNPSPAVCLVAAAV | 461 | Q14137 | |
| WNDTIPSCVVPCSGN | 1791 | Q96PZ7 | |
| FVSWTPCPDCVAKLA | 91 | Q9UH17 | |
| PPSDVLNCENWTTLC | 201 | Q96NH3 | |
| VCLPNKTATCWSLDP | 156 | P12821 | |
| NAYPCVPSCETWVEA | 371 | Q96NS5 | |
| SACNVWRVCEGPKAV | 731 | O75534 | |
| LVKCNAWPCPNTVDC | 166 | P29033 | |
| WTTCQKPETTNCVPQ | 91 | Q9H112 | |
| WCRAGECVSKTPIPE | 526 | Q8TE56 | |
| VSDPWEEKHTCVCPS | 3806 | Q14517 | |
| WSAIKGSCDPSVCLP | 221 | Q96H96 | |
| WCSREIPDPANSTCA | 661 | Q99665 | |
| LLKANNPWPASTSCC | 301 | P58166 | |
| ISRCEQGKWSSPPVC | 436 | P05160 | |
| APWQCAPCSAEKLAL | 26 | P08833 | |
| NCCLWNTTVEVKACP | 111 | Q8WWZ8 | |
| AVVQDCPKQTWCAEA | 8261 | Q7Z5P9 | |
| NISCVERGWSTPPKC | 126 | P36980 | |
| QWSEPPKCLDPCVIS | 196 | P36980 | |
| SISQELKPWVCCAPQ | 136 | Q9NQ92 | |
| WNDSPCNQSLPSICK | 491 | Q9UBG0 | |
| LQPCSSTWEPASCGK | 601 | P10242 | |
| QPVTSDCHPLCAWTK | 4621 | P98088 | |
| CVCAPDCSNITWKGP | 116 | P19883 | |
| DQPAEPWACSQKFPC | 741 | Q9HCN3 | |
| WPFAAISTVCCPEKL | 81 | Q7L5N7 | |
| WATAEATKDCPSPCT | 11 | P14770 | |
| VSWTPCPDCVAKLAE | 91 | Q8IUX4 | |
| PPDVTAKACQVCSAW | 1331 | Q86XA9 | |
| LVAANCSTPRPWVCA | 391 | A4D1S0 | |
| GKWSAVPPTCEEARC | 201 | P20023 | |
| WSPAAPTCEVKSCDD | 346 | P17927 | |
| WSPAAPTCEVKSCDD | 796 | P17927 | |
| LWNSSVPVCEQIFCP | 1761 | P17927 | |
| CWIPVSSDKGSCPQV | 1146 | P01133 | |
| QAPSPCDPVCKIVDW | 1296 | Q8WZ74 | |
| CSCAQPAAEVAAPGW | 46 | Q8IXL6 | |
| AAWGSPCTLCQVDPI | 881 | P35555 | |
| SPSACLVLNWEEPCN | 881 | Q53EP0 | |
| GDWSPAAPRCEVKSC | 336 | Q2VPA4 | |
| MAAPVPWACCAVLAA | 1 | P26992 | |
| PWACCAVLAAAAAVV | 6 | P26992 | |
| PSCVNVSKWNAVICS | 976 | Q9UHN6 | |
| CTASGVWTAPAPVCK | 306 | P16109 | |
| VWTAPAPVCKAVQCQ | 311 | P16109 | |
| CVSSCPEDPWTVGKN | 116 | Q53GD3 | |
| NISCVERGWSTPPKC | 126 | Q03591 | |
| PASPCAWNVCVTRKA | 801 | O75170 | |
| CSVGNCSPEAVWPKT | 181 | O14896 | |
| AWVSDIQECLSPGPC | 366 | Q9NRF2 | |
| LSWEEAQSPANCPAC | 41 | Q96BQ3 | |
| SIWAPQSDVYENCCP | 1536 | A2VDJ0 | |
| ASCANFWINCVEPKP | 1291 | Q9UMZ2 | |
| HPDVKASAAWALCPC | 851 | Q5T2S8 | |
| ENPWDCTCDLVPFKQ | 561 | O94933 | |
| DQVPCEKCGSLVPVW | 631 | Q9Y253 | |
| VDCNCPSKIWDPVCG | 441 | P46721 | |
| SSWSHSPPVCEPVKC | 1891 | Q4LDE5 | |
| CTAPVGLPDCWDAKE | 666 | Q9NRP7 | |
| CTHVQWDCASPDPAA | 146 | Q7Z7M1 | |
| VPTGPWFCRKCESQE | 61 | P55197 | |
| EPSVCLQAACPESWI | 66 | Q9UHP7 | |
| CECPEDPQAWQKTLS | 141 | Q7Z4H8 | |
| ESLPAVCPSDGCTWK | 101 | Q12933 | |
| KCPTEAVCQPLDWGE | 651 | P17040 | |
| VEPAKIAWECPEKNC | 361 | Q9C0C9 | |
| VPCTISAPNECLWTD | 166 | Q99727 | |
| TLCVTGVPENCKPWS | 1316 | P47989 | |
| EALCATQACPEGWSP | 956 | Q9P283 | |
| QPSKTCQVFLSCWAP | 141 | Q9P0V8 | |
| LSWEEAQSPANCPAC | 41 | A6NCK2 | |
| KDCIVTAFSEWTPCP | 736 | Q9C0I4 | |
| TQEKTCPVTPCYSWV | 1291 | Q9C0I4 | |
| VDWACPCPNVTVSEM | 511 | Q8TEU8 |